Clinical Trial Update: Effects of Yeast Beta-glucan on Cognitive Function in Patients With Mild Cognitive Impairment [NA]

View source ↗

Summary

This clinical trial update describes a study evaluating yeast-derived beta-glucan for potential cognitive benefits in mild cognitive impairment and Alzheimer's …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Drugs mentioned

• Yeast beta-glucan (beta-glucan (yeast-derived))

Snippet

Sponsor: Xiaofan Xu | Conditions: Mild Cognitive Impairment, Alzheimer Disease | NA | Status: ACTIVE_NOT_RECRUITING